Linscomb & Williams, Inc. Pfizer Inc Transaction History

Linscomb & Williams, Inc.

  • $1.93 Billion
  • Q2 2024

A detailed history of Linscomb & Williams, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Linscomb & Williams, Inc. holds 235,507 shares of PFE stock, worth $6.99 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
235,507
Previous 229,904 2.44%
Holding current value
$6.99 Million
Previous $6.38 Million 3.29%
% of portfolio
0.34%
Previous 0.33%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$25.26 - $29.6 $141,531 - $165,848
5,603 Added 2.44%
235,507 $6.59 Million
Q1 2024

May 14, 2024
BUY
$25.89 - $29.73 $85,359 - $98,019
3,297 Added 1.45%
229,904 $6.38 Million
Q4 2023

Feb 06, 2024
BUY
$26.13 - $33.94 $301,958 - $392,210
11,556 Added 5.37%
226,607 $6.52 Million
Q3 2023

Oct 10, 2023
SELL
$32.09 - $37.51 $303,154 - $354,356
-9,447 Reduced 4.21%
215,051 $7.13 Million
Q2 2023

Aug 09, 2023
SELL
$36.12 - $41.79 $299,904 - $346,982
-8,303 Reduced 3.57%
224,498 $8.23 Million
Q1 2023

May 11, 2023
SELL
$39.39 - $51.28 $258,083 - $335,986
-6,552 Reduced 2.74%
232,801 $9.5 Million
Q4 2022

Feb 14, 2023
BUY
$41.75 - $54.5 $397,418 - $518,785
9,519 Added 4.14%
239,353 $12.3 Million
Q3 2022

Nov 09, 2022
BUY
$43.76 - $53.42 $134,211 - $163,839
3,067 Added 1.35%
229,834 $10.1 Million
Q2 2022

Aug 15, 2022
SELL
$46.53 - $55.17 $206,500 - $244,844
-4,438 Reduced 1.92%
226,767 $11.9 Million
Q1 2022

May 17, 2022
BUY
$45.75 - $56.69 $135,099 - $167,405
2,953 Added 1.29%
231,205 $12 Million
Q4 2021

Feb 10, 2022
BUY
$41.32 - $61.25 $49,914 - $73,990
1,208 Added 0.53%
228,252 $13.5 Million
Q3 2021

Nov 03, 2021
BUY
$39.25 - $50.42 $182,198 - $234,049
4,642 Added 2.09%
227,044 $9.77 Million
Q2 2021

Aug 10, 2021
BUY
$35.91 - $40.68 $418,351 - $473,922
11,650 Added 5.53%
222,402 $8.71 Million
Q1 2021

May 12, 2021
BUY
$33.49 - $37.77 $292,099 - $329,429
8,722 Added 4.32%
210,752 $7.64 Million
Q4 2020

Feb 11, 2021
BUY
$33.47 - $42.56 $79,524 - $101,122
2,376 Added 1.19%
202,030 $7.44 Million
Q3 2020

Nov 13, 2020
BUY
$31.75 - $37.25 $215,646 - $253,002
6,792 Added 3.52%
199,654 $7.33 Million
Q2 2020

Aug 11, 2020
BUY
$30.12 - $36.54 $1.05 Million - $1.27 Million
34,725 Added 21.96%
192,862 $6.31 Million
Q1 2020

May 11, 2020
BUY
$27.03 - $38.62 $244,216 - $348,931
9,035 Added 6.06%
158,137 $5.16 Million
Q4 2019

Feb 13, 2020
BUY
$32.92 - $37.36 $104,751 - $118,879
3,182 Added 2.18%
149,102 $5.84 Million
Q3 2019

Nov 08, 2019
BUY
$32.49 - $42.13 $274,865 - $356,419
8,460 Added 6.15%
145,920 $5.24 Million
Q2 2019

Aug 06, 2019
SELL
$36.98 - $41.52 $1,294 - $1,453
-35 Reduced 0.03%
137,460 $5.96 Million
Q1 2019

May 09, 2019
SELL
$37.5 - $41.2 $160,200 - $176,006
-4,272 Reduced 3.01%
137,495 $5.84 Million
Q4 2018

Feb 08, 2019
BUY
$38.47 - $43.86 $42,317 - $48,246
1,100 Added 0.78%
141,767 $6.19 Million
Q3 2018

Nov 08, 2018
BUY
$34.47 - $41.81 $14,925 - $18,103
433 Added 0.31%
140,667 $6.2 Million
Q2 2018

Aug 07, 2018
BUY
$32.98 - $35.16 $83,010 - $88,497
2,517 Added 1.83%
140,234 $5.09 Million
Q1 2018

May 04, 2018
BUY
$31.91 - $37.02 $111,206 - $129,014
3,485 Added 2.6%
137,717 $4.89 Million
Q4 2017

Feb 02, 2018
BUY
$33.26 - $35.29 $342,278 - $363,169
10,291 Added 8.3%
134,232 $4.86 Million
Q3 2017

Oct 27, 2017
BUY
$31.0 - $34.15 $3.84 Million - $4.23 Million
123,941
123,941 $4.43 Million

Others Institutions Holding PFE

# of Institutions
3,218
Shares Held
3.71B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Linscomb & Williams, Inc. Portfolio

Follow Linscomb & Williams, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linscomb & Williams, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linscomb & Williams, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email